Light penetration in the human prostate: A whole prostate clinical study at 763 nm

Journal of Biomedical Optics

Volumn 16, Issue 1, 2011, Pages

  Moore, Caroline M ^a,b   Mosse, C Alexander ^a   Allen, Clare ^b   Payne, Heather ^b   Emberton, Mark ^b   Bown, Stephen G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

light penetration; photodynamic therapy; prostate; prostate cancer

Indexed keywords

BOLTZMANN APPROXIMATIONS; CLINICAL STUDY; COMPUTED TOMOGRAPHY; DIFFUSION EQUATIONS; DIODE LASERS; FIBER SEPARATION; HIGH-DOSE RATE BRACHYTHERAPY; HUMAN PROSTATE; ISOTROPIC DETECTORS; LIGHT PENETRATION; LOCALIZED PROSTATE CANCER; NEEDLE INSERTION; PATIENT VARIATION; PENETRATION DEPTH; PROSTATE; PROSTATE CANCER; REACTIVE OXYGEN SPECIES; TISSUE NECROSIS; WAVELENGTH OF LIGHT;

BOLTZMANN EQUATION; COMPUTERIZED TOMOGRAPHY; DISEASES; DRUG THERAPY; NEEDLES; OPTICAL FIBERS; OXYGEN; PARTIAL DIFFERENTIAL EQUATIONS; PLASMONS; TISSUE; TOMOGRAPHY;

PHOTODYNAMIC THERAPY;

ARTICLE; HUMAN; LIGHT; MALE; PATHOPHYSIOLOGY; PHOTOMETRY; PROSTATE TUMOR; RADIATION SCATTERING; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

HUMANS; LIGHT; MALE; NEPHELOMETRY AND TURBIDIMETRY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SCATTERING, RADIATION; SENSITIVITY AND SPECIFICITY;

EID: 79955978523     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3528638     Document Type: Article

References (24)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, Cancer statistics., CA Cancer J. Clin. 59 (4), 225-249 (2009). 10.3322/caac.20006
2. C. Whitehurst, M. L. Pantelides, J. V. Moore, P. J. Brooman, and N. J. Blacklock, In vivo laser light distribution in human prostatic carcinoma., J. Urol. 151 (5), 1411-1415 (1994). (Pubitemid 24121968)
3. L. K. Lee, C. Whitehurst, M. L. Pantelides, and J. V. Moore, In situ comparison of 665 nm and 633 nm wavelength light penetration in the human prostate gland.. Photochem. Photobiol. 62 (5), 882-886 (1995). 10.1111/j.1751-1097.1995.tb09151.x
4. L. K. Lee, C. Whitehurst, M. L. Pantelides, and J. V. Moore, An interstitial light assembly for photodynamic therapy in prostatic carcinoma., BJU Int. 84 (7), 821-826 (1999). 10.1046/j.1464-410x.1999.00314.x (Pubitemid 29500049)
5. T. C. Zhu, A. Dimofte, J. C. Finlay, D. Stripp, T. Busch, J. Miles, Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy., Photochem. Photobiol. 81 (1), 96-105 (2005). 10.1562/2004-06-25-RA- 216.1 (Pubitemid 40327565)
6. K. K. Wang, T. Fau, and T. C. Zhu, Reconstruction of in-vivo optical properties for human prostate using interstitial diffuse optical tomography., Opt. Express 17 (14), 11665-11672 (2009). 10.1364/OE.17.011665
7. T. F. Svensson, E. Alerstam, M. Einarsdottir, M. F. Einarsdottir, K. F. Svanberg, S. Andersson-Engels S Towards accurate in vivo spectroscopy of the human prostate., J. Biophotonics 1 (3), 200-203 (2008). 10.1002/jbio.200710025
8. A. Dimofte, J. C. Finlay, and T. C. Zhu, A method for determination of the absorption and scattering properties interstitially in turbid media., Phys. Med. Biol. 50 (10), 2291-2311 (2005). 10.1088/0031-9155/50/10/008 (Pubitemid 40767817)
9. J. F. Axelsson, J. F. Swartling, and S. Andersson-Engels, In vivo photosensitizer tomography inside the human prostate., Opt. Lett. 34 (3), 232-234 (2009). 10.1364/OL.34.000232
10. C. M. Moore, D. Pense, and M. Emberton Photodynamic therapy for prostate cancer-a review of current status and future promise., Nat. Clin. Pract. Urol. 6 (1), 18-30 (2009). 10.1038/ncpuro1274
11. J. Li, M. D. Altschuler, S. M. Hahn, and T. C. Zhu, Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate., Phys. Med. Biol. 53 (15), 4107-4121 (2008). 10.1088/0031-9155/53/15/007
12. G. Yu, T. Durduran, C. Zhou, T. C. Zhu, J. C. Finlay, T. M. Busch, S. B. Malkowicz, S. M. Hahn, and A. G. Yodh, Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light., Photochem. Photobiol. 82 (5), 1279-1284 (2006). 10.1562/2005-10-19-RA-721 (Pubitemid 44702009)
13. T. C. Zhu, J. Finlay, and S. Hahn, Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy., J. Photochem. Photobiol. B 79 (3), 231-241 (2005). 10.1016/j.jphotobiol.2004.09.013 (Pubitemid 40668442)
14. C. Whitehurst, M. L. Pantelides, J. V. Moore, and N. J. Blacklock, Photodynamic therapy for localised prostatic cancer: light penetration in the human prostate gland., J. Urol. 143 (2), 398-401 (1990). (Pubitemid 20066405)
15. W. G. Zijlstra, A. Buursma, and O. W. van Assendelft, Visible and Near Infrared Absorption Spectra of Human and Animal Haemoglobin Chapter 7: Determination of absorption spectra, pp. 47-51, VSP, Utrecht (2000).
16. E. Alerstam, S. Andersson-Engels, and T. Svensson, White Monte Carlo for time-resolved photon migration., J. Biomed. Opt. 13 (4), 041304 (2008). 10.1117/1.2950319 (Pubitemid 351987909)
17. T. Svensson, E. Alerstam, M. Einarsdttr, K. Svanberg, and S. Andersson-Engels, In vivo optical characterization of human prostate tissue using near-infrared time-resolved spectroscopy., J. Biomed. Opt. 12 (1); 014022 (2007). 10.1117/1.2435175 (Pubitemid 46681974)
18. M. D. Altschuler, T. C. Zhu, J. Li, and S. M. Hahn, Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm., Med. Phys. 32 (12); 3524-3536 (2005). 10.1118/1.2107047
19. S. R. Davidson, R. A. Weersink, M. A. Haider, M. R. Gertner, A. Bogaards, D. Giewercer, A. Scherz, M. D. Sherar, M. Elhilali, J. L. Chin, J. Trachtenberg, and B. C. Wilson, Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer., Phys. Med. Biol. 54 (8), 2293-2313 (2009). 10.1088/0031-9155/54/8/003
20. M. A. Haider, S. R. Davidson, A. V. Kale, R. A. Weersink, A. J. Evans, A. Toi, M. R. Gertner, A. Bogaards, B. C. Wilson, J. L. Chin, M. Elhilali, and J. Trachtenberg, Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide., Radiology 244 (1), 196-204 (2007). 10.1148/radiol.2441060398 (Pubitemid 46981974)
21. J. Trachtenberg, R. A. Weersink, S. R. Davidson, M. A. Haider, A. Bogaards, M. R. Gertner, A. Evans, A. Scherz, J. Savard, J. L. Chin, B. C. Wilson, and M. Elhilali, Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses., BJU Int. 102 (5), 556-562 (2008). 10.1111/j.1464-410X.2008.07753.x
22. J. Trachtenberg, A. Bogaards, R. A. Weersink, M. A. Haider, A. Evans, S. A. McCluskey, A. Scherz, M. R. Gertner, C. Yue, S. Appu, A. Aprikian, J. Savard, B. C. Wilson, and M. Elhilali, Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response., J. Urol. 178 (5), 1974-1979 (2007). 10.1016/j.juro.2007.07.036 (Pubitemid 47554440)
23. R. A. Weersink, A. Bogaards, M. Gertner, S. R. Davidson, K. Zhang, G. Netchev, J. Trachtenberg, and B. C. Wilson, Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities., J. Photochem. Photobiol. B 79 (3), 211-222 (2005). 10.1016/j.jphotobiol.2005.01.008 (Pubitemid 40668440)
24. Q. Chen, S. D. Shetty, L. Heads, F. Bolin, B. Wilson, M. Patterson, L. Sirls, D. Schultz, J. C. Cerny, F. W. Hetzel, Photodynamic therapy in prostate cancer: optical dosimetry and response of normal tissue.. SPIE 1881 Optical methods for tumour treatment and detection, 231-235 1993 (Conference proceeding).